Abstract:Crouzon syndrome, caused by FGFR2 mutations, leads to premature cranial suture fusion and abnormal head shapes. This study used FGFR2C342Y mice to examine the mutation's effect on cranial bone microarchitecture during postnatal development. High‐resolution imaging of frontal and parietal bones in mutant and wild‐type mice revealed significant differences in bone volume fraction, canal and lacunar morphometry, especially in frontal bones. Mutants had larger, less dense lacunae around postnatal days 7–14. These findings improve understanding of Crouzon syndrome and aid in enhancing surgical outcomes. Crouzon syndrome is a congenital craniofacial disorder caused by mutations in the Fibroblast Growth Factor Receptor 2 (FGFR2). It is characterized by the premature fusion of cranial sutures, leading to a brachycephalic head shape, and midfacial hypoplasia. The aim of this study was to investigate the effect of the FGFR2 mutation on the microarchitecture of cranial bones at different stages of postnatal skull development, using the FGFR2C342Y mouse model. Apart from craniosynostosis, this model shows cranial bone abnormalities. High‐resolution synchrotron microtomography images of the frontal and parietal bone were acquired for both FGFR2C342Y/+ (Crouzon, heterozygous mutant) and FGFR2+/+ (control, wild‐type) mice at five ages (postnatal days 1, 3, 7, 14 and 21, n = 6 each). Morphometric measurements were determined for cortical bone porosity: osteocyte lacunae and canals. General linear model to assess the effect of age, anatomical location and genotype was carried out for each morphometric measurement. Histological analysis was performed to validate the findings. In both groups (Crouzon and wild‐type), statistical difference in bone volume fraction, average canal volume, lacunar number density, lacunar volume density and canal volume density was found at most age points, with the frontal bone generally showing higher porosity and fewer lacunae. Frontal bone showed differences between the Crouzon and wild‐type groups in terms of lacunar morphometry (average lacunar volume, lacunar number density and lacunar volume density) with larger, less dense lacunae around the postnatal age of P7–P14. Histological analysis of bone showed marked differences in frontal bone only. These findings provide a better understanding of the pathogenesis of Crouzon syndrome and will contribute to computational models that predict postoperative changes with the aim to improve surgical outcome.

Impairment of Interleukin 11 Signaling As a Novel Pathomechanism Underlying Crouzon-like Syndrome and Pansynostosis

Mutations in the Interleukin Receptor IL11RA Cause Autosomal Recessive Crouzon-like Craniosynostosis

The interleukin-11 receptor variant p.W307R results in craniosynostosis in humans

Molecular characterization of the craniosynostosis‐associated interleukin‐11 receptor variants p.T306_S308dup and p.E364_V368del

FGFR2 Mutation P.cys342arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis Via FGF/FGFR-AMPK-Erk1/2 Axis in Crouzon Syndrome

De novo variants implicate chromatin modification, transcriptional regulation, and retinoic acid signaling in syndromic craniosynostosis

FGFR2 Mutation in a Chinese Family with Unusual Crouzon Syndrome.

Cranial bone microarchitecture in a mouse model for syndromic craniosynostosis

Dosage‐dependent effects of FGFR2W290R mutation on craniofacial shape and cellular dynamics of the basicranial synchondroses

Signaling Mechanisms Underlying Genetic Pathophysiology Of Craniosynostosis

Extensive phenotyping of the orofacial and dental complex in Crouzon syndrome

The structure of the IL‐11 signalling complex provides insight into receptor variants associated with craniosynostosis

New CRISPR/Cas9-based Fgfr2C361Y/+ mouse model of Crouzon syndrome exhibits skull and behavioral abnormalities

Fibroblast Growth Factor Receptor 2 (FGFR2) Mutation Related Syndromic Craniosynostosis

The clinical manifestations, molecular mechanisms and treatment of craniosynostosis

The value of genome-wide analysis in craniosynostosis

A novel therapeutic hypothesis for craniosynostosis syndromes: Clover to clever

Describing Crouzon and Pfeiffer syndrome based on principal component analysis

Craniosynostosis‐associated variants in the IL‐11R complex: new insights and questions

A novel IRF6 mutation causing non-syndromic cleft lip with or without cleft palate in a pedigree.

Ocular manifestations and treatment progress of Crouzon syndrome